These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31481723)

  • 21. Effects of prolonged agmatine treatment in aged male Sprague-Dawley rats.
    Rushaidhi M; Zhang H; Liu P
    Neuroscience; 2013 Mar; 234():116-24. PubMed ID: 23318245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter.
    Reis DJ; Regunathan S
    Ann N Y Acad Sci; 1999 Jun; 881():65-80. PubMed ID: 10415899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of agmatine in neurodegenerative diseases and epilepsy.
    Moretti M; Matheus FC; de Oliveira PA; Neis VB; Ben J; Walz R; Rodrigues AL; Prediger RD
    Front Biosci (Elite Ed); 2014 Jun; 6(2):341-59. PubMed ID: 24896210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine.
    Galea E; Regunathan S; Eliopoulos V; Feinstein DL; Reis DJ
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):247-9. PubMed ID: 8645212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.
    Freitas AE; Egea J; Buendia I; Gómez-Rangel V; Parada E; Navarro E; Casas AI; Wojnicz A; Ortiz JA; Cuadrado A; Ruiz-Nuño A; Rodrigues ALS; Lopez MG
    Mol Neurobiol; 2016 Jul; 53(5):3030-3045. PubMed ID: 25966970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice.
    Freitas AE; Bettio LE; Neis VB; Santos DB; Ribeiro CM; Rosa PB; Farina M; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():143-50. PubMed ID: 24370459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term (5 years), high daily dosage of dietary agmatine--evidence of safety: a case report.
    Gilad GM; Gilad VH
    J Med Food; 2014 Nov; 17(11):1256-9. PubMed ID: 25247837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new target for diagnosis and treatment of CNS disorders: agmatinergic system.
    Uzbay T
    Curr Med Chem; 2012; 19(30):5116-21. PubMed ID: 22934767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agmatine selectively improves behavioural function in aged male Sprague-Dawley rats.
    Rushaidhi M; Collie ND; Zhang H; Liu P
    Neuroscience; 2012 Aug; 218():206-15. PubMed ID: 22609940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice.
    Aricioglu F; Paul IA; Regunathan S
    Neurosci Lett; 2004 Jan; 354(2):153-7. PubMed ID: 14698461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Matheus FC; Aguiar AS; Castro AA; Villarinho JG; Ferreira J; Figueiredo CP; Walz R; Santos AR; Tasca CI; Prediger RD
    Behav Brain Res; 2012 Dec; 235(2):263-72. PubMed ID: 22921927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agmatine protects against beta-amyloid25-35-induced memory impairments in the rat.
    Bergin DH; Liu P
    Neuroscience; 2010 Aug; 169(2):794-811. PubMed ID: 20457225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single intracerebroventricular Aβ25-35 infusion leads to prolonged alterations in arginine metabolism in the rat hippocampus and prefrontal cortex.
    Bergin DH; Jing Y; Zhang H; Liu P
    Neuroscience; 2015 Jul; 298():367-79. PubMed ID: 25907447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide.
    Demehri S; Homayoun H; Honar H; Riazi K; Vafaie K; Roushanzamir F; Dehpour AR
    Neuropharmacology; 2003 Sep; 45(4):534-42. PubMed ID: 12907314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
    Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective Role of Agmatine in Neurological Diseases.
    Xu W; Gao L; Li T; Shao A; Zhang J
    Curr Neuropharmacol; 2018; 16(9):1296-1305. PubMed ID: 28786346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
    Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
    Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute phencyclidine administration on arginine metabolism in the hippocampus and prefrontal cortex in rats.
    Knox LT; Jing Y; Collie ND; Zhang H; Liu P
    Neuropharmacology; 2014 Jun; 81():195-205. PubMed ID: 24534111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice.
    Taksande BG; Faldu DS; Dixit MP; Sakaria JN; Aglawe MM; Umekar MJ; Kotagale NR
    Eur J Pharmacol; 2013 Nov; 720(1-3):115-20. PubMed ID: 24183973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.